/SLDX

SLDX Stock - Stella Diagnostics Inc.

Q: What is the analyst price target for SLDX?

Analyst price target information is not currently available for SLDX.

Q: What is SLDX's market cap?

Market capitalization information is not currently available for SLDX.

Healthcare|Medical - Diagnostics & Research|OTC

$0.03+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.03

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for SLDX

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.55

52W High$0.07

52W Low$0.01

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-1,014,501	$-11,426,950	$-2,449,600	$-4,740,020	$-164,850
Net Income	$-1,235,666	$-5,707,428	$-5,640,820	$-16,640,525	$-262,054
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$-0.00	$-0.02	$-0.03	$-0.17	$-0.00

Company Overview

Stella Diagnostics, Inc., a molecular diagnostics-based company, focuses on enhancing patient management strategies for people living with severe esophageal diseases. Its clinical assays offer physicians insight into the molecular properties of patients' tissue to determine if the disease is stable, progressing, or turning cancerous. The company is also developing diagnostic tools that provides molecular information for providers as compared to the screening protocols. The company was formerly known as JMP Properties, Inc. and changed its name to Stella Diagnostics, Inc. in April 2021. Stella Diagnostics, Inc. is based in Salt Lake City, Utah.

Visit Website

Earnings History & Surprises

SLDX

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-0.00

Q3 2023

EPS Surprise History

Q3 23

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2023	Sep 30, 2023	—	$-0.00	—	—

Frequently Asked Questions about SLDX

What is SLDX's current stock price?

Stella Diagnostics Inc. (SLDX) is currently trading at $0.03 per share. The stock has moved +0.00% today.

What is the analyst price target for SLDX?

No analyst price targets are currently available for this stock.

What sector is Stella Diagnostics Inc. in?

Stella Diagnostics Inc. operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the OTC exchange.

What is SLDX's market cap?

Stella Diagnostics Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does SLDX pay dividends?

No, Stella Diagnostics Inc. does not currently pay a dividend to shareholders.